Bone turnover markers in postmenopausal breast cancer patients treated with fulvestrant.

被引：0
|
作者：
Agrawal, A.
Hannon, R. A.
Cheung, K. L.
Eastell, R.
Robertson, J. F.
机构：
[1] City Hosp, Nottingham NG5 1PB, England
[2] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：47S / 47S
页数：1
相关论文
共 50 条
  • [31] Use of bone turnover markers in postmenopausal osteoporosis
    Eastell, Richard
    Szulc, Pawel
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (11): : 908 - 923
  • [32] Bone turnover markers in the management of postmenopausal osteoporosis
    Brown, Jacques P.
    Albert, Caroline
    Nassar, Bassam A.
    Adachi, Jonathan D.
    Cole, David
    Davison, K. Shawn
    Dooley, Kent C.
    Don-Wauchope, Andrew
    Douville, Pierre
    Hanley, David A.
    Jamal, Sophie A.
    Josse, Robert
    Kaiser, Stephanie
    Krahn, John
    Krause, Richard
    Kremer, Richard
    Lepage, Raymond
    Letendre, Elaine
    Morin, Suzanne
    Ooi, Daylily S.
    Papaioaonnou, Alexandra
    Ste-Marie, Louis-Georges
    CLINICAL BIOCHEMISTRY, 2009, 42 (10-11) : 929 - 942
  • [33] Bone Turnover Markers in Old and Postmenopausal Women
    Chan, Kien
    Nair, Preeti
    Pang, Wee Yang
    Chauhan, Anupam
    Inderjeeth, Charles
    Lim, Ee Mun
    AUSTRALASIAN JOURNAL ON AGEING, 2014, 33 : 46 - 47
  • [34] Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors
    Cepa, M.
    Vaz, C.
    ACTA REUMATOLOGICA PORTUGUESA, 2015, 40 (04): : 323 - 330
  • [35] The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer
    Rupert Bartsch
    Brigitte Mlineritsch
    Michael Gnant
    Thomas Niernberger
    Ursula Pluschnig
    Richard Greil
    Catharina Wenzel
    Paul Sevelda
    Josef Thaler
    Margaretha Rudas
    Michael Pober
    Christoph C. Zielinski
    Guenther G. Steger
    Breast Cancer Research and Treatment, 2009, 115 : 373 - 380
  • [36] The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer
    Bartsch, Rupert
    Mlineritsch, Brigitte
    Gnant, Michael
    Niernberger, Thomas
    Pluschnig, Ursula
    Greil, Richard
    Wenzel, Catharina
    Sevelda, Paul
    Thaler, Josef
    Rudas, Margaretha
    Pober, Michael
    Zielinski, Christoph C.
    Steger, Guenther G.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 115 (02) : 373 - 380
  • [37] BIOCHEMICAL MARKERS OF BONE TURNOVER IN WOMEN WITH SURGICALLY TREATED CARCINOMA OF THE BREAST
    LI, F
    PITT, PI
    SHERWOOD, R
    BARRETT, J
    HOUGHTON, J
    PARSONS, V
    MONIZ, C
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993, 23 (09) : 566 - 571
  • [38] Response of markers of bone turnover and bone density to teriparatide in postmenopausal women previously treated with an antiresorptive drug
    Ettinger, B
    San Martin, J
    Crans, GG
    Pavo, I
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S15 - S15
  • [39] Effects of phytoestrogens on bone turnover in postmenopausal women with a history of breast cancer
    Nikander, E
    Metsä-Heikkilä, M
    Ylikorkala, O
    Tiitinen, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03): : 1207 - 1212
  • [40] Fulvestrant in the treatment of postmenopausal women with advanced breast cancer
    Gradishar, W
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (03) : 445 - 453
12345